Reversed-phase liquid chromatography method to determine COL-3, a matrix metalloproteinase inhibitor, in biological samples

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 799, Issue 2, 2004, Pages 311-321

  Li, Jing ^a   Huynh, Hung ^b   Chan, Eli ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

COL 3; Metalloproteinase inhibitor

Indexed keywords

ALCOHOLS; BIOASSAY; BIOMEDICAL ENGINEERING; CONCENTRATION (PROCESS); ENZYME INHIBITION; MIXTURES; ORGANIC ACIDS; QUALITY CONTROL;

REVERSED-PHASE LIQUID CHROMATOGRAPHY;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

4 DEDIMETHYLAMINOSANCYCLINE; ACETONITRILE; MATRIX METALLOPROTEINASE INHIBITOR; METHANOL; OXALIC ACID;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DEVICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0344234387     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.10.066     Document Type: Article

References (15)

1. Lee H.M., Golub L.M., Cao C. J. Dent. Res. (IADR Abstr.). 77:1998;926.
2. Lokeshwar B.L., Houston-Clark H.L., Selzer M.G., Block N.L., Golub L.M. Adv. Dent. Res. 12:1998;136.
3. Lokeshwar B.L. Ann. N.Y. Acad. Sci. 878:1999;271.
4. Liotta L.A., Stetler-Stevenson W.G. Sem. Cancer Biol. 1:1990;99.
5. Blavier L., Henriet P., Imren S., Declerck Y.A. Ann. N.Y. Acad. Sci. 878:1999;108.
6. Bettany J.T., Wolowacz R.G. Adv. Dent. Res. 12:1998;136.
7. Seftor R.E., Seftor E.A., Delarco J.E. Clin. Exp. Metastasis. 16:1998;217.
8. Selzer M.G., Zhu B., Block N.L., Lokeshwar B. Ann. N.Y. Acad. Sci. 878:1999;678.
9. Rudek M.A., Figg W.D., Dyer V., Dahut W., Turner M.L., Steinberg S.M., Liewehr D.J., Kohler D.R., Pluda J.M., Reed E. J. Clin. Oncol. 19:2001;584.
10. Cianfrocca M., Cooley T.P., Lee J.Y., Rudek M.A., Scadden D.T., Ratner L., Pluda J.M., Figg W.D., Krown S.E., Dezube B.J. J. Clin. Oncol. 20:2002;153.
11. Rudek M.A., March C.L., Bauer K.S. Jr., Pluda J.M., Figg W.D. J. Pharma. Biomed. Anal. 22:2000;1003.
12. Li J., Huynh H., Chan E. Pharma. Res. 19:2002;1655.
13. Pinsuwan S., Alvarez-Nunez F.A., Tabibi S.E., Yalkowsky S.H. J. Pharm. Sci. 88:1999;535.
14. Pinsuwan S., Alvarez-Nunez F.A., Tabibi E.S., Yalkowsky S.H. Int. J. Pharm. 181:1999;31.
15. Blanchflower W.J., McCracken R.J., Haggan A.S., Kennedy D.G. J. Chromatogr. B. 692:1997;351.